These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21340352

  • 1. Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection.
    Marini V, Moretti E, Bermejo D, Basso B.
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):32-7. PubMed ID: 21340352
    [Abstract] [Full Text] [Related]

  • 2. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B, Marini V.
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [Abstract] [Full Text] [Related]

  • 3. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B, Marini V.
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [Abstract] [Full Text] [Related]

  • 4. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B, Cervetta L, Moretti E, Carlier Y, Truyens C.
    Vaccine; 2004 May 07; 22(15-16):1868-72. PubMed ID: 15121297
    [Abstract] [Full Text] [Related]

  • 5. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
    Basso B, Moretti ER, Vottero-Cima E.
    Am J Trop Med Hyg; 1991 Apr 07; 44(4):413-9. PubMed ID: 1828328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A, Sousa OE.
    J Parasitol; 1996 Apr 07; 82(2):363-6. PubMed ID: 8604121
    [Abstract] [Full Text] [Related]

  • 8. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W, Zepeda-Escobar JA, Ochoa-García L, Contreras-Ortíz JME, Tenorio-Borroto E, Barbabosa-Pliego A, Aparicio-Burgos JE, Oros-Pantoja R, Rivas-Santiago B, Díaz-Albiter H, Garg NJ, Vázquez-Chagoyán JC.
    Vaccine; 2019 Jan 07; 37(2):248-257. PubMed ID: 30497833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.
    Flechas ID, Cuellar A, Cucunubá ZM, Rosas F, Velasco V, Steindel M, Thomas Mdel C, López MC, González JM, Puerta CJ.
    BMC Infect Dis; 2009 Nov 25; 9():186. PubMed ID: 19939275
    [Abstract] [Full Text] [Related]

  • 11. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice.
    Saldaña A, Sousa OE, Orn A.
    Scand J Immunol; 1995 Dec 25; 42(6):644-50. PubMed ID: 8552988
    [Abstract] [Full Text] [Related]

  • 12. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE, Sánchez Alberti A, Matos MN, Cerny N, Cardoso AC, Morales C, González G, Cazorla SI, Malchiodi EL.
    PLoS Negl Trop Dis; 2018 Mar 25; 12(3):e0006384. PubMed ID: 29601585
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
    Aparicio-Burgos JE, Zepeda-Escobar JA, de Oca-Jimenez RM, Estrada-Franco JG, Barbabosa-Pliego A, Ochoa-García L, Alejandre-Aguilar R, Rivas N, Peñuelas-Rivas G, Val-Arreola M, Gupta S, Salazar-García F, Garg NJ, Vázquez-Chagoyán JC.
    PLoS Negl Trop Dis; 2015 Apr 25; 9(4):e0003625. PubMed ID: 25853654
    [Abstract] [Full Text] [Related]

  • 15. IgG isotype profiles induced in mice by two Trypanosoma cruzi electronegative antigens.
    Cerban F, Gruppi A, Gea S, Vottero-Cima E.
    Int Arch Allergy Appl Immunol; 1991 Apr 25; 96(1):35-40. PubMed ID: 1721610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can we heal Chagas infection?
    Vega Royero SP, Sibona GJ.
    J Theor Biol; 2014 Jan 07; 340():23-9. PubMed ID: 24029157
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

  • 20. Immune response against Trypanosoma cruzi antigens in Cebus apella monkeys.
    Malchiodi EL, Carbonetto CH, Grana D, Eiguchi de Palmero K, Chiaramonte MG, Falasca CA, Margni RA.
    Trop Med Parasitol; 1993 Jun 03; 44(2):86-90. PubMed ID: 8367672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.